A carregar...
Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor
Prasugrel and ticagrelor are potent oral platelet P2Y(12) inhibitors and are recommended over clopidogrel in patients with acute coronary syndrome (ACS). Oral platelet P2Y(12) inhibitors are characterized by varying degrees of pharmacodynamic response profiles as assessed by a variety of commerciall...
Na minha lista:
| Publicado no: | J Thromb Thrombolysis |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8049919/ https://ncbi.nlm.nih.gov/pubmed/33582955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-021-02386-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|